Antibiotic Resistance: Typhoid, CPE, and Mpox Diagnostic Challenges Emerge Globally

Antibiotic resistance is escalating across multiple fronts, posing significant threats to global health. Typhoid fever is showing increased resistance to last-line antibiotics, while Carbapenemase-Producing Enterobacterales (CPE) are spreading between humans and animals in the US. Simultaneously, advancements in Mpox diagnostics emphasize the importance of proper specimen collection for accurate and timely detection. ## Latest Update Recent research from South Korea has identified skin lesion swabs as the most reliable samples for Mpox diagnosis using real-time PCR, showing higher viral loads compared to oropharyngeal swabs and blood samples. This finding is crucial for optimizing diagnostic accuracy and informing public health response strategies. ## Timeline * **2026-02-25:** A study warns that typhoid fever is rapidly gaining resistance to antibiotics, particularly macrolides and quinolones, with resistant strains detected globally. * **2026-02-26:** Research reveals genetically similar high-risk CPE strains in humans and companion animals in the United States, suggesting potential zoonotic transmission or shared environmental sources. * **2026-03-03:** A study in South Korea identifies skin lesion swabs as the optimal specimens for Mpox diagnosis using real-time PCR. ## What to Watch * Further spread of antibiotic-resistant typhoid and CPE strains, particularly in regions with limited access to alternative treatments. * Development and implementation of integrated surveillance systems to monitor antibiotic resistance across human and animal populations. * Refinement of Mpox diagnostic protocols based on the latest research to improve detection rates and inform public health interventions.